Worried about Your Memory?
HOPE4MCI is a research study for patients diagnosed with mild cognitive impairment due to Alzheimer’s disease (MCI due to AD). The trial is underway and has enrolled 164 patients across 23 sites in the United States and Canada.
The HOPE4MCI Research Trial
The HOPE4MCI Alzheimer’s Trial is assessing the efficacy and safety of an investigational medication to determine if it can treat the symptoms associated with Mild Cognitive Impairment due to Alzheimer’s Disease (MCI due to AD) and control further progression leading to the onset of Alzheimer’s dementia.
What is MCI due to AD?
MCI due to AD is a medical condition between normal aging and early Alzheimer’s dementia during which patients experience memory problems.
Clinical Trials
Clinical trials are required to test all medications before they are approved and available for doctors to prescribe. Volunteers for medical research are essential to evaluate treatments.
Keep Me Posted
We will update you when new information is available on HOPE4MCI.org.